Learn more

LEOPOLDO ESPINOSA ABDALA

Overview
  • Total Patents
    22
About

LEOPOLDO ESPINOSA ABDALA has a total of 22 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Mexico, United States and Brazil. Its main competitors in its focus markets pharmaceuticals are DENG XUEFENG, ELYSIUM THERAPEUTICS INC and SINGH NIKHILESH N.

Patent filings in countries

World map showing LEOPOLDO ESPINOSA ABDALAs patent filings in countries
# Country Total Patents
#1 Mexico 19
#2 United States 2
#3 Brazil 1

Patent filings per year

Chart showing LEOPOLDO ESPINOSA ABDALAs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

Top inventors

# Name Total Patents
#1 Murillo Josefina Santos 8
#2 Ochoa Victor Guillermo Alvarez 7
#3 Armenta Ma Elena Garcia 4
#4 Alvarez Aracely Alvarez 4
#5 Victor Guillermo Alvarez Ochoa 4
#6 Aracely Alvarez Alvarez 4
#7 Alcala Martin Omar Garcia 2
#8 Mendoza Consuelo Flores 2
#9 Armenta Patricia Garcia 2
#10 Armenta Maria Elena Garcia 2

Latest patents

Publication Filing date Title
MXPA05011735A Pharmaceutical compositions combining analgesics and anticonvulsant agents for the treatment of chronic and acute pain.
MXPA05010506A Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders.
MXPA05010505A Pharmaceutical form containing methocarbamol, meloxicam and betamethasone.
BRPI0505046A solid pharmaceutical formulations containing diacerein and meloxicam
MXPA05008575A Sublingual solid pharmaceutical formulations containing meloxicam.
MXPA05008571A Pharmaceutical formulations in the form of solids, semisolids, in suspension, in solution, in emulsion or in syrup, containing clindamycin and one or more members of the azole family.
MXPA05008573A Isoflavones composition for treating menopause physiological symptoms and disorders.
MXPA04009717A Encapsulable diacereine composition and method for manufacturing the same.
MXPA04008461A Solid pharmaceutical compositions in aqueous solution, suspension and emulsion containing meloxicam, cianocobalamina, pyridoxine and thiamine.
MXPA04003136A Solid pharmaceutical formulations in aqueous solution, suspension and emulsion, which contain paracetamol, ascorbic acid and loratadine.
MXPA04001967A Pharmaceutical compositions in aerosol containing beclomethasone dipropionate.
MXPA04001748A Pharmaceutical compositions in aerosol containing sodium chromoglycate.
MXPA04001749A Pharmaceutical compositions in aerosol containing salbutamol in an aqueous solution, and improved process for packaging pharmaceutical compositions in aerosol.
MXPA04001750A Pharmaceutical compositions in aerosol containing fluticasone propionate in an aqueous solution.
MXPA03012050A Pharmaceutical formulations, which are solid, semi-solid, in suspension, emulsion or solution, containing azithromycin and nimesulide.
MXPA02010828A Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
MXPA02000378A Pharmaceutical composition comprising an aminoacid by-product, an essential element involved in the carbohydrates metabolism, a soluble polymer and an extract of marine algae to handle obesity.
MXPA01007685A Pharmaceutical composition comprising a bronchodilator and an antiallergic in aerosol to inhale.
MXPA01007684A Pharmaceutical composition in gel comprising an agonist agent of adrenergic receptors and an antiviral for topical application.
MXPA01004380A Pharmaceutical composition comprising a more effective non-steroidal anti-inflammatory agent and a muscle relaxant.